dactinomycin has been researched along with acyclovir in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiacchio, MA; Corsaro, A; De Clercq, E; Iannazzo, D; Mastino, A; Piperno, A; Rescifina, A; Romeo, G; Romeo, R; Valveri, V | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Burke, RL; Corey, L; Hartog, K; Koelle, D; Sekulovich, RE; Tigges, MA | 1 |
| Nagano, H; Oguro, M | 1 |
| Amici, C; Belardo, G; Rossi, A; Santoro, MG | 1 |
2 review(s) available for dactinomycin and acyclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Inhibitor of eukaryotic DNA synthesis].
Topics: Acyclovir; Animals; Cytarabine; Dactinomycin; DNA Replication; Eukaryotic Cells; Humans; Mice; Nucleic Acid Synthesis Inhibitors; Rats; Vidarabine | 1983 |
5 other study(ies) available for dactinomycin and acyclovir
| Article | Year |
|---|---|
Synthesis and biological activity of isoxazolidinyl polycyclic aromatic hydrocarbons: potential DNA intercalators.
Topics: Animals; Anthracenes; Antineoplastic Agents; Antiviral Agents; Apoptosis; Cell Line, Tumor; Chlorocebus aethiops; DNA; DNA Viruses; Drug Screening Assays, Antitumor; fas Receptor; Humans; Intercalating Agents; Isoxazoles; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Pyrenes; RNA Viruses; Stereoisomerism; Structure-Activity Relationship; Vero Cells | 2006 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
Topics: Acyclovir; Antigens, Viral; CD8 Antigens; Clone Cells; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; Dichlororibofuranosylbenzimidazole; Herpes Simplex; Humans; Immunity, Cellular; Interleukin-2; Recombinant Fusion Proteins; Simplexvirus; T-Lymphocytes, Cytotoxic; Viral Envelope Proteins; Viral Proteins | 1992 |
Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy.
Topics: Acyclovir; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Chlorocebus aethiops; Cycloheximide; Dactinomycin; Drug Design; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Fungal; Herpesvirus 1, Human; Humans; I-kappa B Kinase; Kinetics; Laryngeal Neoplasms; Methionine; Neuroblastoma; NF-kappa B; Prostaglandins A; Protein Serine-Threonine Kinases; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Vero Cells; Virus Replication | 2001 |